World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
16311
World Ranking
2754
National Ranking
7

Eui-Cheol Shin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Eui-Cheol Shin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 416 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Eui-Cheol Shin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Eui-Cheol Shin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Eui-Cheol Shin is affiliated with the Korea Advanced Institute of Science and Technology in South Korea. Their research mainly spans the fields of Medicine and Immunology and Microbiology, with a particular focus on Immunology, Oncology, and Infectious Diseases. Other areas of expertise include Molecular Biology and Epidemiology.

Their work covers various topics such as:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • T-cell and B-cell Immunology
  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • COVID-19 Clinical Research Studies
  • CAR-T cell therapy research

Frequent publication venues for their research include:

  • Immune Network
  • The Journal of Immunology
  • Journal of Hepatology
  • Clinical Cancer Research
  • SSRN Electronic Journal

Eui-Cheol Shin has collaborated extensively with several co-authors including:

  • Su-Hyung Park
  • June-Young Koh
  • Min-Seok Rha
  • Seong Jin Choi
  • Hye Won Jeong

The research contributions include notable papers such as:

  • "Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19," 2020, Science Immunology
  • "The type I interferon response in COVID-19: implications for treatment," 2020, Nature Reviews Immunology
  • "Type I and III interferon responses in SARS-CoV-2 infection," 2021, Experimental & Molecular Medicine
  • "PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19," 2020, Immunity
  • "SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells," 2021, Nature Communications

This body of work reflects a sustained research interest in immune mechanisms related to COVID-19 and the broader context of viral infections and cancer immunotherapy.

Best Publications

  • Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.

    Jeong Seok Lee;Seongwan Park;Hye Won Jeong;Jin Young Ahn

  • MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells

    Patrizia Leone;Eui-Cheol Shin;Federico Perosa;Angelo Vacca

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • The type I interferon response in COVID-19: implications for treatment.

    Jeong Seok Lee;Eui Cheol Shin

  • Immune responses and immunopathology in acute and chronic viral hepatitis

    Eui-Cheol Shin;Pil Soo Sung;Pil Soo Sung;Su-Hyung Park

  • Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions

    Michelina Nascimbeni;Eui-Cheol Shin;Luis Chiriboga;David E. Kleiner

  • Immunosenescent CD8+ T Cells and C-X-C Chemokine Receptor Type 3 Chemokines Are Increased in Human Hypertension

    Jong Chan Youn;Hee Tae Yu;Beom Jin Lim;Myoung Ju Koh

  • Type I and III interferon responses in SARS-CoV-2 infection.

    You Me Kim;Eui Cheol Shin

  • Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

    C.G. Kim;K.H. Kim;K.H. Kim;K.-H. Pyo;C.-F. Xin

  • Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma

    Hyung-Don Kim;Gi-Won Song;Seongyeol Park;Min Kyung Jung

  • Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays

    Hyun O. Kim;Han Soo Kim;Jong Chan Youn;Eui Cheol Shin

  • VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers.

    Chang Gon Kim;Mi Jang;Youngun Kim;Galam Leem

  • Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality.

    Hojun Choi;Youngeun Kim;Amin Mirzaaghasi;Jaenyoung Heo

  • Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.

    Chulhee Choi;Joo Young Park;Jeonggi Lee;Jung-Hee Lim

  • YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma

    Min Hwan Kim;Chang Gon Kim;Sang-Kyum Kim;Sang Joon Shin

  • SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.

    Jae Hyung Jung;Min-Seok Rha;Min-Seok Rha;Moa Sa;Hee Kyoung Choi

  • PD-1-Expressing SARS-CoV-2-Specific CD8 + T Cells Are Not Exhausted, but Functional in Patients with COVID-19.

    Min Seok Rha;Hye Won Jeong;Jae Hoon Ko;Seong Jin Choi

  • Predictors of mortality in Middle East respiratory syndrome (MERS)

    Ki Ho Hong;Jae Phil Choi;Seon Hui Hong;Jeewon Lee

  • Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection

    Eui-Cheol Shin;Ulrike Seifert;Takanobu Kato;Charles M. Rice

  • The first-week proliferative response of peripheral blood PD-1+CD8+ T cells predicts the response to anti-PD-1 therapy in solid tumors

    Kyung Hwan Kim;Jinhyun Cho;Bo Mi Ku;Jiae Koh;Jiae Koh

  • Activation or exhaustion of CD8 + T cells in patients with COVID-19.

    Min-Seok Rha;Min-Seok Rha;Eui-Cheol Shin

Frequent Co-Authors

Su-Hyung Park
Su-Hyung Park Korea Advanced Institute of Science and Technology
Barbara Rehermann
Barbara Rehermann National Institute of Diabetes and Digestive and Kidney Diseases
Myung-Ju Ahn
Myung-Ju Ahn Sungkyunkwan University
Chulhee Choi
Chulhee Choi Korea Advanced Institute of Science and Technology
Charles M. Rice
Charles M. Rice Rockefeller University
Kwang Hyub Han
Kwang Hyub Han Yonsei University
Young Seok Ju
Young Seok Ju Korea Advanced Institute of Science and Technology
Keunchil Park
Keunchil Park The University of Texas MD Anderson Cancer Center
Se-Hoon Lee
Se-Hoon Lee Sungkyunkwan University
Young Ki Choi
Young Ki Choi Institute for Basic Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare fields like nursing can open diverse career opportunities. A Doctor of Nursing Practice degree offers advanced clinical skills and leadership roles, with insights into the doctor of nursing practice salary showcasing its promising financial prospects across the USA.

Nurses aiming to specialize can consider becoming an Acute Care Nurse Practitioner. Transitioning from a Family Nurse Practitioner to acute care demands specific certification, and learning about the acute care certification for fnp is essential for this career path.

For those looking to fast-track their qualifications, many universities offer accelerated NP programs online. These programs allow students to gain nurse practitioner credentials efficiently, balancing flexibility with rigorous education.

Additionally, individuals without a nursing background might explore 12-month accelerated nursing programs online for non nurses. These programs enable career changers to enter the nursing field quickly and align their skills with growing healthcare demands.

Best Scientists Citing Eui-Cheol Shin

Trending Scientists

Recently Published Articles